CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

出版年份 2008 全文链接

标题

作者

关键词

出版物

Volume -, Issue -, Pages -

出版商

American Society for Clinical Investigation

发表日期

2008-09-19

DOI

10.1172/jci35449

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now